SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a memecoin on the Bitcoin network, is trending as the community rallies around its potential as the first fair-launched meme on Bitcoin L2 with big names and whales watching. Discussions revolve around its strong community, decentralized nature, and the possibility of reaching $1, with some highlighting its role in driving demand for Bitcoin blockspace. The 'DOG Army' is actively promoting the token, emphasizing its unique position within the Bitcoin ecosystem.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential licensing deal with AstraZeneca and positive sentiment surrounding its cancer drug, ivonescimab. The community is actively discussing the possibility of a significant upfront payment and the potential for the drug to challenge existing treatments. Anticipation is building as investors await further news and data releases, with some highlighting the stock's high short interest as a catalyst for a potential squeeze.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as a potential Real World Asset (RWA) coin, drawing comparisons to $XRP.X and $XLM.X. The community highlights its low market cap and potential for integration with the XRP ledger, viewing it as an early opportunity. Community members are actively discussing where to buy the coin and sharing enthusiasm for its potential gains.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as community members rally around its potential to become the leading memecoin on the Bitcoin network, with some suggesting it could surpass Dogecoin. Key talking points include its fair launch, decentralized nature, and strong community backing. Many believe it's poised for significant growth and exchange listings.

Numeraire

Numeraire is trending as traders discuss a recent investment from a major US bank into the AI-based crypto hedge fund, which some believe could lead to significant growth. The community is actively analyzing price charts, identifying potential breakout points, and anticipating further upward momentum. With a relatively low circulating supply, many are speculating on substantial long-term gains.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation about a potential buyout or partnership with Incannex ($IXHL), driven by positive clinical trial data for a sleep apnea pill that could disrupt the CPAP market. The community is closely watching for an announcement, especially given that a ResMed executive is on Incannex's advisory board, with some speculating this is a strategic move before Phase 3 trials.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community discusses its potential for significant gains, with some drawing comparisons to other recently successful tokens. The token's chart setup and appealing levels are generating interest, while others speculate about potential scams. The recent listing and overall market conditions abroad are also being mentioned as potential catalysts.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders discuss its low float and potential for a significant price surge, reminiscent of other recent low float runners. Community members are highlighting the stock's scarce shares and growing watcher count, suggesting a possible squeeze. Some are pointing to a recent land sale that could boost NAV.

Tidal Trust III - Fundstrat Granny Shots US Large Cap ETF

Fundstrat Granny Shots US Large Cap ETF

The Fundstrat Granny Shots US Large Cap ETF ($GRNY) is trending as investors discuss its holdings and recent performance, with many referencing Tom Lee's bullish outlook and stock-picking strategy. Community members are weighing the ETF's expense ratio against its potential for long-term growth and diversification, with some speculating about future inclusion of specific assets. The ETF is gaining traction as a way to invest in multiple key investment themes and is being compared to benchmark indexes.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

BBBY is trending as the ticker reactivates, sparking confusion and discussion among traders about Overstock's acquisition of the Bed Bath & Beyond brand and its implications for previous shareholders. The community is actively debating the company's future, potential partnerships, and the possibility of a short squeeze, drawing comparisons to the $GME saga. Some investors express skepticism, citing past financial difficulties, while others see potential in the company's blockchain initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Samsara's Q2 Earnings Surpass Expectations, Revenues Rise Y/Y

IOT's Q2 earnings beat estimates with strong revenues and ARR growth, boosted by new high-value customers and margin expansion.

SAIC Q2 Earnings Beat Estimates, Stock Falls 7% on Revenue Miss

Science Applications tops Q2 earnings with a 77% surge but lags revenues, driving shares down nearly 7% and prompting a guidance cut.

Salesforce Q2 Earnings Surpass Estimates, Revenues Rise Y/Y

CRM beats Q2 earnings and revenues, fueled by AI-driven demand, margin gains, and a raised full-year outlook.

HPE Q3 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Up 2%

Hewlett Packard's third-quarter revenues rise 19% to $9.1 billion, fueled by AI servers, networking and GreenLake, while earnings and outlook beat estimates.

Zscaler Q4 Earnings Beat: Will Strong Guidance Lift the Stock Higher?

ZS' Q4 earnings soar, beating estimates with 21% revenue growth and initiates strong FY26 guidance.

AI Adoption and Cloud Growth to Boost Salesforce's Q2 Earnings?

CRM's Q2 results are likely to reflect the benefits of the rising demand for AI and cloud. However, macro headwinds and slower deal cycles may limit the upside.

F5 (FFIV) Up 1.6% Since Last Earnings Report: Can It Continue?

F5 (FFIV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ambarella Stock Soars 19% as Q2 Earnings and Revenues Crush Estimates

AMBA stock jumps nearly 19% after Q2 earnings and revenues beat estimates, fueled by strength in IoT and automotive growth.

CrowdStrike Beats on Q2 Earnings, Stock Down on Dim Q3 Outlook

CRWD's Q2 earnings and revenues beat estimates with strong Falcon adoption, but rising costs and a weak Q3 outlook weigh on investor sentiment.

NVIDIA Q2 Earnings Beat, Stock Falls on Data Center Sales Miss

NVDA's Q2 earnings and revenues top estimates, but shares slide as Data Center sales miss analyst expectations.

F5, Inc. engages in the business of multi-cloud application services. The firm's products include F5 distributed cloud services, F5 NGINX, F5 BIG-IP, and F5 Systems. It operates through the following geographical segments: Americas, EMEA, and APAC. The company was founded on February 26, 1996 and is headquartered in Seattle, WA.

Current Price	$315.89
Prev Close	$314.35
Open	$314.35
Dividend Yield	0.00%
50-Day Moving Average	$307.56
Beta	1.09
Avg. Volume	478,505.95
PE Ratio	27.85

52-Week High	$334.00
52-Week Low	$197.34
Market Capitalization	$18.15B
EPS (Annual)	$9.55
Price to Book	5.27
Revenue Per Employee	$429,482.99
Enterprise Value/EBITDA	N/A

FFIV
F5 Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FFIV News

FFIV F5 Inc